Influence of aspirin on SR-BI expression in human carotid plaques

Autor: Ivan Tancevski, Andreas Wehinger, Ruediger Seiler, Josef R. Patsch, Philipp Eller, Sandra Frotschnig, Andreas Ritsch, Bernhard Foeger, Stefan Frantz, Julia M. Huber, Wilfried Schgoer
Rok vydání: 2009
Předmět:
Zdroj: Atherosclerosis. 206:234-238
ISSN: 0021-9150
Popis: Background We recently showed that aspirin promotes scavenger receptor class-B type I (SR-BI) protein expression in vitro in primary human macrophages and in vivo in resident peritoneal macrophages of mice. Methods We compared SR-BI and CD68 expression in carotid atherosclerotic specimens from endarterectomized patients with ( n =38) or without ( n =19) low-dose aspirin medication (100mg/day) prior to endarterectomy. Results We found no differences concerning expression of CD68, indicating that aspirin did not influence macrophage content within atherosclerotic plaques. However, aspirin increased the expression of SR-BI protein in the analyzed specimens. In human THP-1-derived macrophages, induction of SR-BI protein by aspirin was abrogated by concomitant pharmacological inhibition of nuclear factor-kappa B (NF-κB). In in vitro experiments employing cultured primary macrophages from NF-κB/p50 KO mice, aspirin was not able to influence SR-BI expression. Additionally, no considerable effects on SR-BI expression were observed in vivo in resident macrophages of NF-κB/p50 KO mice orally treated with low or high doses of aspirin, respectively. Conclusions We suggest that aspirin treatment might lead to enhanced expression of SR-BI in human plaque macrophages and that this effect is dependent on the presence of NF-κB.
Databáze: OpenAIRE